CR845

difelikefalin · Cara Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for CR845, covering 2014-05-19 to 2024-01-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus [Phase 2]

See pricing